Published in Immunol Rev on January 01, 1981
Isolation and expression of cDNA clones encoding a human receptor for IgG (Fc gamma RII). J Exp Med (1987) 1.60
Physiology of IgD. IV. Enhancement of antibody production in mice bearing IgD-secreting plasmacytomas. J Exp Med (1984) 1.37
Human Fc gamma RIII: cloning, expression, and identification of the chromosomal locus of two Fc receptors for IgG. Proc Natl Acad Sci U S A (1989) 1.36
The low-affinity receptor for IgE (CD23) on B lymphocytes is spatially associated with HLA-DR antigens. J Exp Med (1988) 1.29
Isotype regulation of antibody production: T-cell hybrids can be selectively induced to produce IgG1 and IgG2 subclass-specific suppressive immunoglobulin-binding factors. Proc Natl Acad Sci U S A (1983) 1.19
Characteristics and function of Fc receptors on human lymphocytes. Immunology (1982) 1.09
Generation of IgE-binding and IgG-binding factors from human lymphoblastoid cell lines. Immunology (1984) 1.05
IgE class-restricted tolerance induced by neonatal administration of soluble or cell-bound IgE. J Exp Med (1983) 0.97
Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction. J Exp Med (1993) 0.97
Potentiating and suppressive IgE-binding factors are expressed by a single cloned gene. Proc Natl Acad Sci U S A (1987) 0.86
Serum Fc gamma-receptor-like molecules in primary biliary cirrhosis: a possible immunoregulatory mechanism. Immunology (1984) 0.85
IgD-binding factors from mouse T lymphocytes. Proc Natl Acad Sci U S A (1986) 0.85
A transforming growth factor beta-like immunosuppressive factor in immunoglobulin G-binding factor. J Exp Med (1995) 0.82
Functional and biochemical characterization of a secreted I-J(+) suppressor factor that binds to immunoglobulin. J Exp Med (1986) 0.78
Enhancement of antibody responses by IgD-binding factors induced by anti-IgD treatment of spleen cells. Proc Natl Acad Sci U S A (1988) 0.78
A B-cell hybridoma product inhibiting antibody secretion via 5'-nucleotidase. Clin Exp Immunol (1985) 0.78
The plasma protein which inhibits complement-mediated prevention of immune precipitation is an Fc binding protein. Immunology (1989) 0.77
Increased levels of soluble low-affinity Fc gamma receptors (IgG-binding factors) in the sera of tumour-bearing mice. Clin Exp Immunol (1992) 0.76
Immunoglobulin Fc receptor molecules on Xenopus laevis splenocytes. Immunology (1988) 0.76
Spontaneous release of Fc gamma receptors from normal human peripheral blood lymphocytes in vitro. Immunology (1987) 0.75
Isolation of labile Fcgamma-receptors from human peripheral blood lymphocytes and production of an antiserum. Immunology (1985) 0.75
Characterization of the Fc(IgG) receptor on the pluripotential leukaemia cell K-562. Clin Exp Immunol (1985) 0.75
An alternative role for specific antibody in neutrophil bactericidal activity against highly pathogenic group B streptococci. Br J Exp Pathol (1982) 0.75
Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol (1993) 7.27
Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther (2000) 2.95
Hepatitis C virus infection protein network. Mol Syst Biol (2008) 2.91
Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med (1997) 2.90
Stimulation of lymphocytes by autologous leukaemic cells in acute leukaemia. Nature (1969) 2.75
Antibody-induced redistribution of HL-A antigens at the cell surface. Eur J Immunol (1972) 2.58
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet (2004) 2.55
Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science (1992) 2.41
The structure of a human type III Fcgamma receptor in complex with Fc. J Biol Chem (2001) 2.33
Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res (1999) 2.23
The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity (1995) 2.12
Measles virus haemagglutinin induces down-regulation of gp57/67, a molecule involved in virus binding. J Gen Virol (1993) 2.07
Complement-dependent B-cell activation by cobra venom factor and other mitogens? J Exp Med (1974) 1.97
CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol (1995) 1.93
Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3). J Immunol (1975) 1.82
Independence of H-2K and H-2D antigenic determinants on the surface of mouse lymphocytes. J Exp Med (1973) 1.76
Effects of interferon on antibody synthesis in vitro. J Immunol (1974) 1.73
Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet (1993) 1.72
Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J Natl Cancer Inst (1998) 1.71
Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest (1995) 1.70
Tyrosine-containing motif that transduces cell activation signals also determines internalization and antigen presentation via type III receptors for IgG. Nature (1992) 1.60
The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. J Med Genet (2009) 1.59
A monoclonal antibody recognizes a human cell surface glycoprotein involved in measles virus binding. J Gen Virol (1992) 1.58
Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer. Lancet (2001) 1.58
Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates beta 2 integrins on lymphokine-activated killer cells. Eur J Immunol (1993) 1.58
Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo. J Exp Med (1998) 1.57
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy. Cancer Metastasis Rev (2011) 1.55
Working principles in the immune system implied by the "peptidic self" model. Proc Natl Acad Sci U S A (1987) 1.55
Independence of HL-A antigens and immunoglobulin determinants on the surface of human lymphoid cells. Eur J Immunol (1972) 1.52
Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infections. J Virol (1996) 1.51
Relationship between the EBV-associated membrane antigen on Burkitt lymphoma cells and the viral envelope, demonstrated by immunoferritin labelling. Int J Cancer (1971) 1.50
Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines. J Immunol (2001) 1.48
Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J Immunol (2000) 1.47
Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Eur J Immunol (1998) 1.47
T-cell hybrids bear Fcgamma receptors and secrete suppressor immunoglobulin binding factor. Nature (1979) 1.47
Measles virus induces functional TRAIL production by human dendritic cells. J Virol (2000) 1.43
Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J Immunol (2000) 1.41
CD40 signaling in human dendritic cells is initiated within membrane rafts. EMBO J (2000) 1.37
Suppression of in vitro antibody synthesis by immunoglobulin-binding factor. J Exp Med (1975) 1.37
Mechanism of measles virus-induced suppression of inflammatory immune responses. Immunity (2001) 1.36
Highly resolved chemical imaging of living cells by using synchrotron infrared microspectrometry. Proc Natl Acad Sci U S A (1998) 1.36
Soluble mediators of T-B interaction. Eur J Immunol (1973) 1.34
Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J Exp Med (1995) 1.30
Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation. J Immunol (1998) 1.28
Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level. J Exp Med (1979) 1.27
Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer (1995) 1.25
Role of B cell receptor Ig alpha and Ig beta subunits in MHC class II-restricted antigen presentation. Immunity (1995) 1.25
A role for the alphavbeta3 integrin in the transmigration of monocytes. J Cell Biol (1998) 1.23
Expression of HLA-DR antigens at the surface of mouse L cells co-transfected with cloned human genes. Nature (1983) 1.22
CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J Immunol (2001) 1.22
Role of associated gamma-chain in tyrosine kinase activation via murine Fc gamma RIII. EMBO J (1992) 1.20
Isotype regulation of antibody production: T-cell hybrids can be selectively induced to produce IgG1 and IgG2 subclass-specific suppressive immunoglobulin-binding factors. Proc Natl Acad Sci U S A (1983) 1.19
Differentiation of murine B cell precursors in agar culture. Frequency, surface marker analysis and requirements for growth of clonable pre-B cells. Eur J Immunol (1984) 1.18
Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation. Am J Transplant (2008) 1.17
Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus. J Virol (2000) 1.16
Cell-to-cell contact via measles virus haemagglutinin-CD46 interaction triggers CD46 downregulation. J Gen Virol (1995) 1.15
Suppression of mitogen-induced peripheral B cell differentiation by soluble Fc gamma receptors released from lymphocytes. Eur J Immunol (1980) 1.14
Chemical imaging of nucleic acids, proteins and lipids of a single living cell. Application of synchrotron infrared microspectrometry in cell biology. Cell Mol Biol (Noisy-le-grand) (1998) 1.13
Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients. Br J Cancer (1994) 1.12
Modulation of interleukin-18 expression in human colon carcinoma: consequences for tumor immune surveillance. Int J Cancer (1999) 1.11
Macrophage inflammatory protein-1alpha is induced by human immunodeficiency virus infection of monocyte-derived macrophages. Blood (1996) 1.11
T cell hybridomas coexpressing Fc receptors (FcR) for different isotypes. II. IgA-induced formation of suppressive IgA binding factor(s) by a murine T hybridoma bearing Fc gamma R and Fc alpha R. J Immunol (1983) 1.10
Immunoglobulin-binding factor present on and produced by thymus-processed lymphocytes (T cells). Cell Immunol (1974) 1.10
Measles virus receptor properties are shared by several CD46 isoforms differing in extracellular regions and cytoplasmic tails. J Gen Virol (1994) 1.10
Measles virus and dendritic cell functions: how specific response cohabits with immunosuppression. Curr Top Microbiol Immunol (2003) 1.09
The role of the Fc receptor (FcR) of thymus-derived lymphocytes. II. Presence of FcR on suppressor cells and direct involvement in suppression. Eur J Immunol (1977) 1.09
Octamerization enables soluble CD46 receptor to neutralize measles virus in vitro and in vivo. J Virol (2000) 1.08
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings. Cancer Immunol Immunother (2010) 1.08
Interferon enhances the expression of Fc gamma receptors. J Immunol (1980) 1.08
Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules. Eur J Immunol (1991) 1.07
The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J Immunol (2000) 1.07
Interleukin-18: biological properties and clinical implications. Eur Cytokine Netw (2000) 1.06
Relationship between HL-A antigens and beta-2-microglobulin as studied by immunofluorescence on the lymphocyte membrane. J Exp Med (1974) 1.06
Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors. J Immunol (1996) 1.05
Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors. J Immunol (1999) 1.05
Ion channel blockers inhibit B cell activation at a precise stage of the G1 phase of the cell cycle. Possible involvement of K+ channels. J Immunol (1990) 1.05
ViralORFeome: an integrated database to generate a versatile collection of viral ORFs. Nucleic Acids Res (2009) 1.04
PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis. Mol Biol Cell (2000) 1.04
Death by neglect as a deletional mechanism of peripheral tolerance. Int Immunol (1999) 1.03
Hormonal regulation of the immune response. II. Influence of pituitary and adrenal activity on immune responsiveness in vitro. Cell Immunol (1971) 1.01
Measles virus nucleocapsid protein binds to FcgammaRII and inhibits human B cell antibody production. J Exp Med (1997) 1.01
Measles virus infection induces terminal differentiation of human thymic epithelial cells. J Virol (1999) 1.00
Signal regulatory proteins negatively regulate immunoreceptor-dependent cell activation. J Biol Chem (1999) 1.00
Crucial role of tumor necrosis factor receptor 1 expression on nonhematopoietic cells for B cell localization within the splenic white pulp. J Exp Med (1998) 0.99
Recombinant interleukin 2-activated natural killer cells regulate IgG2a production. Eur J Immunol (1990) 0.98
Cross-linking of IgG receptors inhibits membrane immunoglobulin-stimulated calcium influx in B lymphocytes. J Cell Biol (1993) 0.98
Induction of tumor necrosis factor-alpha production by mast cells via Fc gamma R. Role of the Fc gamma RIII gamma subunit. J Immunol (1992) 0.98
Regulation of ITAM signaling by specific sequences in Ig-beta B cell antigen receptor subunit. J Biol Chem (1996) 0.98
Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated Fc gammaRIIB during negative regulation of IgE-dependent mouse mast cell activation. Immunol Lett (1996) 0.97
Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study. J Clin Oncol (1996) 0.97
Characterization of accessory cells required for helper T cell induction in vitro: evidence for a phagocytic, Fc-receptor, and Ia-bearing cell type. J Immunol (1980) 0.97
Measles virus nucleoprotein induces cell-proliferation arrest and apoptosis through NTAIL-NR and NCORE-FcgammaRIIB1 interactions, respectively. J Gen Virol (2005) 0.97
Different patterns of calcium signaling triggered through two components of the B lymphocyte antigen receptor. J Biol Chem (1994) 0.97